Corteva misses Q4 revenue expectations

Corteva

03/02/2026 21:39

Overview

Agriculture firm's Q4 revenue missed analyst expectations

Operating EBITDA for Q4 decreased 15% yr/yr

Company remains on track for planned separation in H2 of 2026

Outlook

Corteva expects 2026 operating EBITDA to be $4.0 bln to $4.2 bln

Company anticipates 2026 operating EPS of $3.45 to $3.70 per share

Corteva sees mixed global agriculture outlook with pricing pressures in key regions

Result Drivers

SEED TECHNOLOGY - Demand for latest technology and productivity improvements drove Seed performance

CROP PROTECTION VOLUME - Volume growth in new products and biologicals supported Crop Protection results, despite pricing pressure

CASH GENERATION - Robust cash generation driven by earnings growth and efficient working capital management

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$3.91 bln
$4.24 bln (15 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the agricultural chemicals peer group is "buy"

Wall Street's median 12-month price target for Corteva Inc is $80.00, about 9.3% above its February 2 closing price of $73.20

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nPn8PQYzKa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)